Let’s Win Pancreatic Cancer Video Highlights Patient Perspective from the SHARON Trial
Let’s Win Pancreatic Cancer recently released “Let’s Win Pancreatic Cancer Survivors—Year Nine,” marking the ninth year since the organization’s founding. The video presents multiple patient perspectives, including reflections on survivorship in pancreatic cancer. A patient and his spouse share his experience in the SHARON clinical trial. The video also includes Sharon Seibel, M.D., in whose […]
CURE Features Eileen O’Reilly, M.D., Discussing SHARON Trial Data Presented at ESMO
CURE interviewed Eileen O’Reilly, M.D. about the SHARON clinical trial and data presented at the recent European Society for Medical Oncology (ESMO) conference. Dr. O’Reilly discusses the scientific rationale for the study, the patient population under investigation, and the early observations that motivated continued clinical evaluation of the approach. Dr. O’Reilly states: “The SHARON study […]
General Oncology Announces Promising Preliminary Phase 1 Results from SHARON Trial Presented at ESMO 2025
Novel regimen GO-4, combining melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cells shows manageable adverse reactions and a strong signal of efficacy in patients with BRCA-related pancreatic cancer Boston, MA, October 18, 2025 – General Oncology, Inc. (“General Oncology” or the “Company”), a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers, today announced preliminary results from its ongoing Phase […]
Empowered Patient Podcast – Jeff Glazier – CEO of General Oncology
In the Empowered Patient Podcast with Karen Jagoda, Jeff Glazier, CEO of General Oncology, discusses GO-4, General Oncology’s investigational cancer therapy. Listen to the podcast here. Download a transcript of the podcast here. In the podcast, he states: “We’re actually taking a different approach than a lot are. And I would say there are really […]
General Oncology to Present Preliminary Phase 1 Results from SHARON Trial in Patients with BRCA/PALB2-mutated Pancreatic and Breast Cancer at ESMO 2025
BOSTON, MA, October 13, 2025 — General Oncology, Inc. (“General Oncology” or the “Company”), a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers, today announced that it will deliver a poster presentation featuring preliminary results from its ongoing Phase 1 SHARON trial (NCT04150042) evaluating GO-4: the Company’s patented Advanced Redox Modulation regimen […]
The BioHub Podcast: Episode 76 – Abid Ansari – CFO of General Oncology
In an interview with Tom Weir in The BioHub Podcast, Abid Ansari, CFO of General Oncology, discusses: Abid’s journey through the field and mentorship. General Oncology’s key differentiators in such a crowded oncology landscape. Fundraising in today’s notoriously challenging market, and Abid’s ‘tricks of the trade’. Listen on Spotify. Watch on YouTube.
General Oncology Announces Formation of Scientific Advisory Board
Boston, MA, September 23, 2025 – General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers, today announced the formalization of its Scientific Advisory Board (SAB). The SAB brings together world-renowned leaders in oncology research and clinical care to guide General Oncology’s mission of transforming cancer treatments through innovative science […]
Let’s Win Pancreatic Cancer Interviews Sharon Seibel, in Whose Honor the SHARON Trial Was Named
Let’s Win Pancreatic Cancer recently published a video featuring Sharon Seibel, M.D., a long-term survivor of pancreatic cancer whose extraordinary case directly led to the scientific work that became the SHARON clinical trial at General Oncology. More than a decade ago, Sharon pursued a treatment approach outside of a formal clinical trial. Her outcome prompted […]
General Oncology to Participate in Three Upcoming Conferences
Boston, MA, May 12, 2025 – General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class treatments for metastatic cancers, today announced that members of its senior management team will participate in three upcoming conferences in May and June 2025: Pharma Partnering US Summit […]
General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer
Boston, MA, April 8, 2025 – General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers, today announced the appointment of Abid Ansari as Chief Financial Officer (CFO). Abid brings over 20 years of experience in the biotechnology sector with expertise in financial strategy and corporate development for public and […]